Consensus statement for the diagnosis and treatment of drug-induced lung injuries

Respir Investig. 2013 Dec;51(4):260-77. doi: 10.1016/j.resinv.2013.09.001. Epub 2013 Oct 28.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Acute Lung Injury / chemically induced*
  • Acute Lung Injury / diagnosis*
  • Acute Lung Injury / epidemiology
  • Acute Lung Injury / therapy
  • Amiodarone / adverse effects
  • Anti-Arrhythmia Agents / adverse effects
  • Anti-Infective Agents / adverse effects
  • Antineoplastic Agents / adverse effects
  • Antirheumatic Agents / adverse effects
  • Biomarkers / blood
  • Bronchial Provocation Tests
  • Diagnostic Imaging
  • Drugs, Chinese Herbal / adverse effects
  • Hematologic Tests
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Interferons / adverse effects
  • Japan / epidemiology
  • Lung Diseases, Interstitial / chemically induced*
  • Lung Diseases, Interstitial / diagnosis*
  • Lung Diseases, Interstitial / epidemiology
  • Lung Diseases, Interstitial / therapy
  • Lymphocyte Activation
  • Risk Factors
  • Severity of Illness Index

Substances

  • Anti-Arrhythmia Agents
  • Anti-Infective Agents
  • Antineoplastic Agents
  • Antirheumatic Agents
  • Biomarkers
  • Drugs, Chinese Herbal
  • Immunosuppressive Agents
  • Interferons
  • Amiodarone